名稱 | KRAS G12C-R68M/BaF3 Kinase |
型號(hào) | CBP73372 |
報(bào)價(jià) | |
特點(diǎn) | KRAS G12C-R68M/BaF3 Kinase |
產(chǎn)品搜索
相關(guān)文章
- 選擇性組蛋白去乙?;敢种苿┰谀[瘤免疫治療中的作用及前景
- ATCC細(xì)胞冷凍保存方法
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
- 強(qiáng)強(qiáng)聯(lián)合!IBM與MIT開(kāi)展腫瘤藥物抗藥性研究
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機(jī)制
- 上海細(xì)胞中心人員需了解的專業(yè)“術(shù)語(yǔ)”
- 圣誕節(jié)日,這株腫瘤細(xì)胞你的圣誕襪里,有嗎
- 潛力十足的T細(xì)胞療法,我們用得起嗎?
- 示蹤細(xì)胞在活體成像技術(shù)中的應(yīng)用
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73372KRAS G12C-R68M/BaF3 Kinase
- 詳細(xì)內(nèi)容
CBP73372 | |
I. Introduction | |
Cell Line Name: | KRAS G12C-R68M/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
KRAS, KRAS proto-oncogene, GTPase, is a member of the small GTPase superfamily and a key regulator of the MAPK, PI3K/AKT/mTOR pathways (PMID: 23622131). KRAS mutations are identified in a wide range of cancers (PMID: 28666118). | |
III. Representative Data | |
1.Sanger of KRAS G12C-R68M/BaF3 Figure 1. KRAS(NM_033360.4):c.34G>T p.G12C Figure 2. KRAS(NM_004985.5): c.203G>T p.R68M | |
2. Anti-proliferation assay Figure 3. CTG Proliferation Assay of KRAS G12C/R68M BaF3 Cells (C2). |